| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 22.567 | 62.724 | 61.406 | 51.491 | 58.662 | 122.605 | 137 |
| Total Income - EUR | - | - | - | 31.779 | 67.146 | 65.443 | 55.418 | 62.394 | 126.270 | 3.697 |
| Total Expenses - EUR | - | - | - | 28.151 | 20.037 | 45.311 | 23.953 | 17.036 | 66.616 | 14.770 |
| Gross Profit/Loss - EUR | - | - | - | 3.628 | 47.109 | 20.132 | 31.465 | 45.358 | 59.654 | -11.073 |
| Net Profit/Loss - EUR | - | - | - | 3.384 | 46.064 | 19.578 | 31.012 | 44.771 | 58.468 | -11.073 |
| Employees | - | - | - | 2 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dei Bioderma S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 30.420 | 25.304 | 20.732 | 16.384 | 12.646 | 9.031 | 5.321 |
| Current Assets | - | - | - | 17.977 | 55.323 | 77.488 | 97.271 | 54.607 | 66.915 | 12.442 |
| Inventories | - | - | - | 6 | 20.422 | 0 | 38 | 371 | 0 | 0 |
| Receivables | - | - | - | 17.384 | 30.160 | 76.766 | 80.512 | 46.514 | 48.156 | 10.846 |
| Cash | - | - | - | 588 | 4.741 | 722 | 16.720 | 7.722 | 18.759 | 1.595 |
| Shareholders Funds | - | - | - | 2.404 | 48.421 | 67.082 | 96.606 | 44.820 | 57.665 | 8.073 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 17.530 | 8.714 | 12.230 | 1.365 | 10.471 | 10.019 | 5.033 |
| Income in Advance | - | - | - | 29.511 | 24.517 | 20.016 | 15.684 | 11.963 | 8.262 | 4.656 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2042 - 2042" | |||||||||
| CAEN Financial Year |
2042
|
|||||||||
Comments - Dei Bioderma S.r.l.